Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MPO | P05164 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 5/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.35 |
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.32 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31583096 | 0.83 | L3MBTL1 (0.40) | L3MBTL1MTNR1AMTNR1BSLC22A12LMNA | |
| SCHEMBL31583078 | 0.78 | L3MBTL1 (0.38) | L3MBTL1MTNR1AMTNR1BP2RX7LMNA | |
| SCHEMBL31582612 | 0.78 | MPO (0.34) | MPOSLC22A12LMNAHPGDCNR1 | |
| SCHEMBL31583192 | 0.74 | L3MBTL1 (0.38) | L3MBTL1MTNR1AMTNR1BSMN1; SMN2 | |
| SCHEMBL31582540 | 0.72 | MPO (0.44) | L3MBTL1MPOLMNASMN1; SMN2KDM4C | |
| SCHEMBL31583259 | 0.71 | L3MBTL1 (0.36) | L3MBTL1MTNR1AMTNR1BLMNASMN1; SMN2 | |
| SCHEMBL31582832 | 0.71 | SMN1; SMN2 (0.36) | L3MBTL1MTNR1AMTNR1BSLC22A12LMNA | |
| SCHEMBL31582800 | 0.70 | L3MBTL1 (0.35) | L3MBTL1MTNR1AMTNR1BCNR1CNR2 | |
| SCHEMBL31582852 | 0.69 | RECQL (0.46) | L3MBTL1HPGDSMN1; SMN2 | |
| SCHEMBL31583004 | 0.69 | MTNR1A (0.36) | L3MBTL1MTNR1AMTNR1BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025106644-A1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ALPHA-V BETA-1 INTEGRIN | MORPHIC THERAPEUTIC, INC. (US) | 2025-05-22 | — | — | WO | disclosed |